With obesity rates rising across the western world, the campaign against sugar is here to stay. DouxMatok is hoping to tap into this movement and improve the health of the population by changing the way we taste sugar, making it more potent so people consume less of it – ideally, around 30% less. 


For years, pharmaceutical companies have been using what they refer to as a “drug carrier”. This is a chemical compound or molecule that transports the drug to the intended receptors within the body. DouxMatok is replicating this process with sugar. Although the average American consumes between 150 and 170 pounds of sugar in a single year, much of it is never tasted. It just goes straight to a person’s belly, adding to their caloric intake without providing the benefit of getting that sweet taste. DouxMatok has created a carrier model that makes the sugar molecule travel straight to the sweetness receptors on a person’s taste buds and stay there as long as possible, increasing the efficacy of sugar within their diet.


Last year the World Health Organisation reported that an estimated 1.9 billion adults were overweight in 2016, with 650 million of them classified as obese.

The number of people with diabetes has also risen dramatically in the last few decades, increasing from 108 million people globally in 1980 to 422 million in 2014.


The company recently raised an $8.1m Series A round, funded by Pitango Venture Capital.